PharmaNutrition最新文献

筛选
英文 中文
6-Hydroxydopamine-induced decrease in dopaminergic neurons is avoided by effusol and dehydroeffusol, unique phenanthrenes of Juncus effusus 多巴胺能神经元的6-羟基多巴胺诱导的减少可被流苏醇和脱氢流苏醇(流苏中特有的菲类化合物)所避免
IF 2.4
PharmaNutrition Pub Date : 2024-07-18 DOI: 10.1016/j.phanu.2024.100403
Misa Katahira , Haruna Tamano , Toshiyuki Fukuda , Hiroki Ikeda , Yasuhito Akagi , Shinji Ikeura , Atsushi Takeda
{"title":"6-Hydroxydopamine-induced decrease in dopaminergic neurons is avoided by effusol and dehydroeffusol, unique phenanthrenes of Juncus effusus","authors":"Misa Katahira ,&nbsp;Haruna Tamano ,&nbsp;Toshiyuki Fukuda ,&nbsp;Hiroki Ikeda ,&nbsp;Yasuhito Akagi ,&nbsp;Shinji Ikeura ,&nbsp;Atsushi Takeda","doi":"10.1016/j.phanu.2024.100403","DOIUrl":"10.1016/j.phanu.2024.100403","url":null,"abstract":"<div><h3>Background</h3><p>Excess influx of extracellular Zn<sup>2+</sup> into nigral dopaminergic neurons play a crucial role for 6-hydroxydopamine (6-OHDA)-induced Parkinson's disease in rats. On the basis of neurodegeneration by Zn<sup>2+</sup> dysregulation, we aimed to clarify the effect of effusol and dehydroeffusol, unique phenanthrenes from <em>Juncus effusus</em> on dopaminergic degeneration.</p></div><div><h3>Methods</h3><p>The decrease in dopaminergic neurons was assessed by tyrosine hydroxylase immunostaining 14 days after 6-OHDA injection into the substantia nigra pars compacta (SNpc) of rats.</p></div><div><h3>Results</h3><p>The decrease in dopaminergic neurons induced by 6-OHDA was avoided by co-injection of 1<em>-</em>naphthyl acetyl spermine (NASPM), a selective blocker of Zn<sup>2+</sup>-permeable GluR2-lacking AMPA receptors, which blocked the increase in intracellular Zn<sup>2+</sup>, supporting the involvement of Zn<sup>2+</sup> dysregulation in dopaminergic degeneration. Moreover, either effusol or dehydroeffusol was co-injected with 6-OHDA into the SNpc. The decrease in dopaminergic neurons was avoided by effusol and dehydroeffusol. The increases in intracellular Zn<sup>2+</sup> and H<sub>2</sub>O<sub>2</sub> in the SNpc induced by 6-OHDA were also avoided by effusol and dehydroeffusol.</p></div><div><h3>Conclusions</h3><p>The present study first indicates that effusol and dehydroeffusol avoid the decrease in dopaminergic neurons in the SNpc via reducing production of reactive oxygen species induced by intracellular Zn<sup>2+</sup> dysregulation after injection of 6-OHDA into the rat SNpc. It is likely that effusol and dehydroeffusol serve as nutraceutical components to protect dopaminergic degeneration, perhaps via regulating presynaptic excitation of glutamatergic neurons in the SNpc.</p></div>","PeriodicalId":20049,"journal":{"name":"PharmaNutrition","volume":"29 ","pages":"Article 100403"},"PeriodicalIF":2.4,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141960388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The synbiotic solution: Evaluating safety and efficacy in antibiotic-associated dysbiosis - A randomized, double-blind, placebo-controlled pre-clinical study with sprague dawley rats 合成益生菌解决方案:评估抗生素相关性菌群失调的安全性和疗效--以 Sprague Dawley 大鼠为对象的随机、双盲、安慰剂对照临床前研究
IF 2.4
PharmaNutrition Pub Date : 2024-07-14 DOI: 10.1016/j.phanu.2024.100402
A.V. Sarangarajan , Adarsh Jain , Jenifer L. Ferreir , Anushree , Aniket Dhanawat , Pankita Ahir , Sanjeev Acharya
{"title":"The synbiotic solution: Evaluating safety and efficacy in antibiotic-associated dysbiosis - A randomized, double-blind, placebo-controlled pre-clinical study with sprague dawley rats","authors":"A.V. Sarangarajan ,&nbsp;Adarsh Jain ,&nbsp;Jenifer L. Ferreir ,&nbsp;Anushree ,&nbsp;Aniket Dhanawat ,&nbsp;Pankita Ahir ,&nbsp;Sanjeev Acharya","doi":"10.1016/j.phanu.2024.100402","DOIUrl":"10.1016/j.phanu.2024.100402","url":null,"abstract":"<div><h3>Background</h3><p>Antibiotic therapy, vital for combating infections, often disrupts the intricate balance of gut bacteria, resulting in \"gut dysbiosis.\" This study aimed to assess the safety and efficacy of a Synbiotic supplement in alleviating antibiotic-associated dysbiosis in Sprague Dawley (SD) rats.</p></div><div><h3>Methods</h3><p>A double-blind, placebo-controlled pre-clinical study was conducted over a minimum of 10 consecutive days. The study employed five distinct groups for evaluation, with a focus on the Synbiotic group comprising probiotic and prebiotic components. The administered dose was 1 billion CFU with 100 mg Fossence®.</p></div><div><h3>Results</h3><p>The Synbiotic supplement demonstrated significant positive outcomes across diverse parameters. Compared to the disease control group, the Synbiotic group displayed enhancements in fecal output ratio, feed conversion ratio, total weight gain, and specific growth ratio. Histopathological data supported these findings, affirming the Synbiotic supplementation's potential in mitigating antibiotics' adverse effects on gut health. No mortalities or major symptoms were recorded, confirming the supplement's safety<strong>.</strong></p></div><div><h3>Conclusions</h3><p>The study underscores the efficacy of Synbiotics in enhancing gastrointestinal health in SD rats. The identified effective dose of 1 billion CFU with 100 mg Fossence® necessitates further clinical investigation. This suggests Synbiotics as a compelling approach to address antibiotic-associated gut dysbiosis, warranting further exploration in humans for potential applications in maintaining a healthy gut and overall well-being.</p></div>","PeriodicalId":20049,"journal":{"name":"PharmaNutrition","volume":"29 ","pages":"Article 100402"},"PeriodicalIF":2.4,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141705458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of omega-3 supplementation on serum leptin levels: A systematic review and meta-analysis 补充欧米茄-3 对血清瘦素水平的影响:系统回顾和元分析
IF 2.4
PharmaNutrition Pub Date : 2024-07-14 DOI: 10.1016/j.phanu.2024.100401
Mostafa Shahraki Jazinaki , Hossein Bahari , Yasaman Aali , Mohammad Rashidmayvan
{"title":"Impact of omega-3 supplementation on serum leptin levels: A systematic review and meta-analysis","authors":"Mostafa Shahraki Jazinaki ,&nbsp;Hossein Bahari ,&nbsp;Yasaman Aali ,&nbsp;Mohammad Rashidmayvan","doi":"10.1016/j.phanu.2024.100401","DOIUrl":"10.1016/j.phanu.2024.100401","url":null,"abstract":"<div><h3>Background</h3><p>Omega-3 fatty acids have gained attention for their potential impact on appetite regulation and energy balance. Research suggests that omega-3 supplementation may influence leptin production and sensitivity, potentially affecting body weight and metabolic health. Therefore, this meta-analysis aimed to assess the effect of omega-3 supplementation on serum leptin levels.</p></div><div><h3>Methods</h3><p>A comprehensive search of the literature was conducted up to March 2024 in PubMed, Scopus, and Web of Science to find suitable randomized clinical trials (RCTs). The selected trials were subjected to heterogeneity tests using the I² statistic. Random effects models were examined based on the heterogeneity tests, and the pooled data were calculated as weighted mean differences (WMD) with a 95 % confidence interval (CI).</p></div><div><h3>Results</h3><p>Of the 357 papers, 25 eligible RCTs (with 29 treatment arms) were included in the present meta-analysis. Our findings indicated that omega-3 supplementation failed to change serum leptin levels significantly (WMD: −0.38 ng/mL; 95 %CI: −1.96–1.19; P =0.63). However, significant heterogeneity was detected among the included studies (I<sup>2</sup> = 85.6 %, P &lt; 0.001).</p></div><div><h3>Conclusions</h3><p>This meta-analysis revealed that omega-3 supplementation had no significant impact on circulating leptin levels. However, it seems that omega-3 supplementation with a dosage of more than 2 g/day may significantly reduce serum leptin levels.</p></div>","PeriodicalId":20049,"journal":{"name":"PharmaNutrition","volume":"29 ","pages":"Article 100401"},"PeriodicalIF":2.4,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141694085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eicosapentaenoic acid-rich omega-3 fatty acids supplementation may improve vision in dry age-related macular degeneration or Stargardt disease, as shown in MADEOS, a prospective, randomized, multicentre, double-blind, placebo-controlled pilot study 补充富含二十碳五烯酸的欧米伽-3 脂肪酸可改善干性老年性黄斑变性或斯塔尔加特病的视力,这是一项前瞻性、随机、多中心、双盲、安慰剂对照试验研究 MADEOS 的结果
IF 2.4
PharmaNutrition Pub Date : 2024-07-10 DOI: 10.1016/j.phanu.2024.100400
Ekatherine Prokopiou , Panagiotis Kolovos , Haritini Tsangari , Saddek Mohand-Said , Luca Rossetti , Leonardo Mastropasqua , Francesco Bandello , Tassos Georgiou
{"title":"Eicosapentaenoic acid-rich omega-3 fatty acids supplementation may improve vision in dry age-related macular degeneration or Stargardt disease, as shown in MADEOS, a prospective, randomized, multicentre, double-blind, placebo-controlled pilot study","authors":"Ekatherine Prokopiou ,&nbsp;Panagiotis Kolovos ,&nbsp;Haritini Tsangari ,&nbsp;Saddek Mohand-Said ,&nbsp;Luca Rossetti ,&nbsp;Leonardo Mastropasqua ,&nbsp;Francesco Bandello ,&nbsp;Tassos Georgiou","doi":"10.1016/j.phanu.2024.100400","DOIUrl":"https://doi.org/10.1016/j.phanu.2024.100400","url":null,"abstract":"<div><h3>Background</h3><p>This study investigates the effects of eicosapentaenoic acid (EPA)-rich omega-3 fatty acids on dry age-related macular degeneration (AMD) and Stargardt disease.</p></div><div><h3>Methods</h3><p>MADEOS is a prospective, randomized, multicenter, double-blind, placebo-controlled pilot study, which assessed the impact of omega-3 fatty acids on best corrected visual acuity, blood omega-6/omega-3 ratio, and perceived vision and mood using a questionnaire in patients with dry AMD or Stargardt disease. Participants received either the active product (3660 mg of EPA and DHA; 14 patients) or placebo (sunflower oil; 7 patients) daily for 24 weeks. Measurements were taken at screening (Visit 1), 12 weeks (Visit 3), and 24 weeks (Visit 4). Comparisons were made within and between groups.</p></div><div><h3>Results</h3><p>The mean letters gained at Visits 3 and 4 were significantly different between the groups (p=0.002). The active group showed a mean gain of 6 ETDRS letters from Visit 1 to Visit 4 (p=0.003). The mean arachidonic acid/EPA ratio in the active group significantly decreased from Visit 1 (5.84 ± 1.05) to Visit 4 (1.47 ± 0.16, p=0.002). The questionnaire scores were similar at Visit 3 but higher for the active group at Visit 4 (9.38 ± 3.35 vs. 7.28 ± 2.36).</p></div><div><h3>Conclusion</h3><p>EPA-rich omega-3 supplementation may improve both objective and subjective vision in patients with dry AMD or Stargardt disease, offering a potentially simple, safe, and cost-effective approach to enhancing quality of life.</p></div>","PeriodicalId":20049,"journal":{"name":"PharmaNutrition","volume":"29 ","pages":"Article 100400"},"PeriodicalIF":2.4,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213434424000264/pdfft?md5=85a4d81c7eda2b13633958603a317c07&pid=1-s2.0-S2213434424000264-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141607673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Herbal medicines and botanicals for managing insomnia, stress, anxiety, and depression: A critical review of the emerging evidence focusing on the Middle East and Africa 治疗失眠、压力、焦虑和抑郁的草药和植物药:以中东和非洲为重点,对新出现的证据进行批判性审查
IF 2.4
PharmaNutrition Pub Date : 2024-07-02 DOI: 10.1016/j.phanu.2024.100399
Morten Georg Jensen , Michael Goode , Michael Heinrich
{"title":"Herbal medicines and botanicals for managing insomnia, stress, anxiety, and depression: A critical review of the emerging evidence focusing on the Middle East and Africa","authors":"Morten Georg Jensen ,&nbsp;Michael Goode ,&nbsp;Michael Heinrich","doi":"10.1016/j.phanu.2024.100399","DOIUrl":"https://doi.org/10.1016/j.phanu.2024.100399","url":null,"abstract":"<div><h3>Background</h3><p>Mental health issues affect millions of people globally, imposing significant emotional and economic burdens. These involve multiple pathogenic mechanisms, including oxidative stress and neuroinflammation. With an annual global death estimated at 9 million, neurological disorders are the second leading cause of death. This review aims to explore the benefits of 15 medicinal plants available within MEA and provide researchers with knowledge on how these herbal medicines could alleviate symptoms associated with changes in mental health.</p></div><div><h3>Method</h3><p>Academic databases were searched to find relevant studies on traditional medicinal herbs used in the MEA for the treatment of mental health related issues like sleep, anxiety and depression.</p></div><div><h3>Result</h3><p>The MEA region has the highest prevalence of major depressive and anxiety disorders globally, with conventional treatments often involving medications that alter neurotransmitters, potentially leading to adverse effects. Given the concerns about long-term drug use, there is growing interest in multi-targeted approaches using medicinal plants. These offer a cost-effective, less hazardous alternative, especially for those with chronic, comorbid conditions. Medicinal plant-based food supplements are increasing within the MEA region, where cultural and traditional usage of such plants is extensive. However, the practical application of these supplements is often limited in real-world scenarios.</p></div><div><h3>Conclusion</h3><p>While medicinal plant-based food supplements show potential as a cost-effective and a more suitable alternative for individuals with chronic and comorbid conditions in the MEA region, further research is needed to overcome the limitations in their practical application including a focus on real world data.</p></div>","PeriodicalId":20049,"journal":{"name":"PharmaNutrition","volume":"29 ","pages":"Article 100399"},"PeriodicalIF":2.4,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213434424000252/pdfft?md5=b322cc8b1a69edcdd888a444f75244e0&pid=1-s2.0-S2213434424000252-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141543566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Daily white tea intake reprograms hepatic metabolism and improves the enzymatic antioxidant defence system of rats with prediabetes 每日摄入白茶可重塑糖尿病前期大鼠的肝脏代谢,改善酶抗氧化防御系统
IF 3.2
PharmaNutrition Pub Date : 2024-06-01 DOI: 10.1016/j.phanu.2024.100393
Ana C. Silveira , Pedro Fontes Oliveira , Marco G. Alves , Luís Rato , Branca M. Silva
{"title":"Daily white tea intake reprograms hepatic metabolism and improves the enzymatic antioxidant defence system of rats with prediabetes","authors":"Ana C. Silveira ,&nbsp;Pedro Fontes Oliveira ,&nbsp;Marco G. Alves ,&nbsp;Luís Rato ,&nbsp;Branca M. Silva","doi":"10.1016/j.phanu.2024.100393","DOIUrl":"https://doi.org/10.1016/j.phanu.2024.100393","url":null,"abstract":"<div><h3>Background</h3><p>Prediabetes (PrDM) poses a significant risk for the development of Diabetes Mellitus (DM). Preventing the transition to type 2 DM is of utmost importance, and identifying novel dietary agents with both antioxidant and antidiabetic properties is crucial. This study aims to assess the potential of regular white tea (WTEA) consumption in alleviating the detrimental effects of PrDM on hepatic metabolism and redox state.</p></div><div><h3>Methods</h3><p>To achieve this, we divided 18 male Wistar rats into three groups: a control group and two prediabetes (PrDM) groups. In one of the PrDM groups, water consumption was replaced with white tea (WTEA). After a two-month period, we evaluated the hepatic metabolic profile using 1H NMR. Additionally, we measured total antioxidant potential, the activities of antioxidant enzymes, and various oxidative parameters, including protein nitration and carbonylation, lipid peroxidation, and levels of H2A.X and phosphorylated H2A.X.</p></div><div><h3>Results</h3><p>PrDM induced a decline in hepatic catabolic metabolism and the activities of key antioxidant enzymes, including superoxide dismutase, glutathione reductase, catalase, and levels of phosphorylated H2A.X. However, when PrDM rats consumed WTEA, a remarkable restoration occurred. Specifically, WTEA intake reinstated glutathione reductase and catalase activities and elevated superoxide dismutase activity in the liver compared to normoglycemic conditions. Moreover, enhancements were noted in overall antioxidant capacity and a reduction in lipid peroxidation in the rat liver.</p></div><div><h3>Conclusion</h3><p>PrDM significantly impacts liver metabolism and antioxidant defenses, but the consumption of WTEA, a plant-based functional beverage, exhibits potent hepatoprotective capabilities against PrDM-induced oxidative stress.</p></div>","PeriodicalId":20049,"journal":{"name":"PharmaNutrition","volume":"28 ","pages":"Article 100393"},"PeriodicalIF":3.2,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141291688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effective vitamin D supplementation among women with gestational diabetes and perinatal outcomes: Results of a clinical trial 妊娠糖尿病妇女有效补充维生素 d 与围产期结果:临床试验结果
IF 3.2
PharmaNutrition Pub Date : 2024-06-01 DOI: 10.1016/j.phanu.2024.100395
Nathalia Ferreira Antunes de Almeida , Claudia Saunders , Thais Rangel Bousquet Carrilho , Lenita Zajdenverg , Cleber Nascimento do Carmo , Elisabete Caldeiras Queiroz Neves , Juliana Braga , Bárbara Folino Nascimento , Mayara Santos , Patricia de Carvalho Padilha
{"title":"Effective vitamin D supplementation among women with gestational diabetes and perinatal outcomes: Results of a clinical trial","authors":"Nathalia Ferreira Antunes de Almeida ,&nbsp;Claudia Saunders ,&nbsp;Thais Rangel Bousquet Carrilho ,&nbsp;Lenita Zajdenverg ,&nbsp;Cleber Nascimento do Carmo ,&nbsp;Elisabete Caldeiras Queiroz Neves ,&nbsp;Juliana Braga ,&nbsp;Bárbara Folino Nascimento ,&nbsp;Mayara Santos ,&nbsp;Patricia de Carvalho Padilha","doi":"10.1016/j.phanu.2024.100395","DOIUrl":"10.1016/j.phanu.2024.100395","url":null,"abstract":"<div><h3>Background</h3><p>Gestational diabetes mellitus (GDM) is a common clinical condition worldwide that affects the health of women and their offspring. Theaim was to assess whether a protocol of vitamin D supplementation among women with GDM was efficient in increasing vitamin D levels at the end of pregnancy, and to explore whether the supplementation reduced the occurrence of adverse neonatal outcomes among those women.</p></div><div><h3>Methods</h3><p>A controlled clinical trial.Vitamin D was assessed at baseline (&lt; 28 gestational weeks) and after 8 weeks of intervention and categorized as adequate (<u>&gt;</u>30 ng/mL), insufficient (20–29.9 ng/mL), or deficient (&lt;20 ng/mL). Women with insufficiency received 2000 UI daily of vitamin D supplementation and those with deficiency received 7000 UI daily for 8 weeks. The outcomes 25-hydroxyvitamin D [25(OH)D] concentration at 28 weeks, glycemic control, total gestational weight gain, birth weight, and gestational age at birth. Statistical analyses included Chi-squared or Fisher’s exact tests for categorical variables and Kruskall–Wallis test for continuous variables to compare the groups.</p></div><div><h3>Results</h3><p>At baseline, 59 pregnant women with GDM allocated to the study group were evaluated at baseline.Vitamin D status changed between the first and second examinations in 70 % of the women investigated. The insufficient and deficient groups showed a tendency towards improvement in glycemic control (p = 0.096). No differences were identified between the groups in terms of the neonatal variables.</p></div><div><h3>Conclusion</h3><p>Supplementation was effective in adjusting serum vitamin D levels, and its effect on glycemic control appeared promising in this preliminary investigation.</p></div>","PeriodicalId":20049,"journal":{"name":"PharmaNutrition","volume":"29 ","pages":"Article 100395"},"PeriodicalIF":3.2,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141276552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cellular and molecular mechanisms of action of epigallocatechin gallate on bladder cancer: A comprehensive systematic review 表没食子儿茶素没食子酸酯对膀胱癌的细胞和分子作用机制:全面系统综述
IF 3.2
PharmaNutrition Pub Date : 2024-06-01 DOI: 10.1016/j.phanu.2024.100392
Hussein Riyadh Abdul Kareem Al-Hetty , Abdulrahman T. Ahmed , Hiba Muwafaq Saleem , Haitham L. Abdulhadi , Thikra Majid Muhammed , Loay H. Ali
{"title":"Cellular and molecular mechanisms of action of epigallocatechin gallate on bladder cancer: A comprehensive systematic review","authors":"Hussein Riyadh Abdul Kareem Al-Hetty ,&nbsp;Abdulrahman T. Ahmed ,&nbsp;Hiba Muwafaq Saleem ,&nbsp;Haitham L. Abdulhadi ,&nbsp;Thikra Majid Muhammed ,&nbsp;Loay H. Ali","doi":"10.1016/j.phanu.2024.100392","DOIUrl":"https://doi.org/10.1016/j.phanu.2024.100392","url":null,"abstract":"<div><h3>Background</h3><p>Bladder cancer is a common type of cancer that originates in the cells of the bladder. Research studies have indicated that green tea has positive effects on human health, including its ability to combat cancer. Catechins, which account for 12–25 percent of the dried weight of green tea, are one of its main components. In this study, we conducted a systematic review of the literature to examine the effects of epigallocatechin gallate (EGCG) on bladder cancer.</p></div><div><h3>Method</h3><p>The study followed the guidelines outlined in the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) statements . We searched various databases including Web of Sciences, PubMed, Embase, Science Direct, Scopus, and the Cochrane databases, up until October 2022<strong>.</strong> Two reviewers independently screened the data and assessed the risk of bias. After applying the inclusion criteria, a total of 34 studies were included in the analysis<strong>.</strong></p></div><div><h3>Results</h3><p>The evidence from the study indicates that EGCG can regulate the progression of bladder cancer through various mechanisms. These mechanisms include reducing inflammation, decreasing the production of reactive oxygen species (ROS), managing oxidative stress (OS), inhibiting angiogenesis, suppressing cancer cell proliferation, controlling the cell cycle, inducing autophagy, stimulating tumor gene suppressors (TGS), and promoting apoptosis.</p></div><div><h3>Conclusion</h3><p>Based on the substantial beneficial effects of EGCG on bladder cancer progression, it has the potential to be used as a therapeutic approach. However, it is important to note that there is a lack of clinical trials involving human subjects. Therefore, further research involving human participants is necessary to reach a more precise conclusion<strong>.</strong></p></div>","PeriodicalId":20049,"journal":{"name":"PharmaNutrition","volume":"28 ","pages":"Article 100392"},"PeriodicalIF":3.2,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141239948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of vitamin D administration on serum uric acid concentrations: A systematic review and meta-analysis of clinical trials 服用维生素 D 对血清尿酸浓度的影响:临床试验的系统回顾和荟萃分析
IF 3.2
PharmaNutrition Pub Date : 2024-06-01 DOI: 10.1016/j.phanu.2024.100391
Luis E. Simental-Mendía , Yéssika Weyman-Vela , Mario Simental-Mendía
{"title":"Effect of vitamin D administration on serum uric acid concentrations: A systematic review and meta-analysis of clinical trials","authors":"Luis E. Simental-Mendía ,&nbsp;Yéssika Weyman-Vela ,&nbsp;Mario Simental-Mendía","doi":"10.1016/j.phanu.2024.100391","DOIUrl":"10.1016/j.phanu.2024.100391","url":null,"abstract":"<div><h3>Background</h3><p>It has been suggested the potential uric acid-lowering effect of vitamin D; however, clinical trials evaluating the impact of vitamin D administration on serum uric acid levels are scarce. The aim of this meta-analysis of clinical trials was to examine the effect of vitamin D administration on serum uric acid concentrations.</p></div><div><h3>Methods</h3><p>A systematic search was performed in PubMed-MEDLINE, Scopus, Web of Science, ClinicalTrials.gov, and Google Scholar databases. Randomized clinical trials (parallel or cross-over design) with data at baseline and at the end of intervention. Trials without intervention, without control group, and incomplete data of uric acid concentrations were excluded. A random-effects model and sensitivity analysis generic inverse variance method were used for the meta-analysis.</p></div><div><h3>Results</h3><p>Meta-analysis was carried out using a random-effects model and sensitivity analysis. The meta-analysis of seven clinical trials, involving 959 participants, indicated a significant reduction of uric acid levels after vitamin D administration (WMD: −16.64 µmol/L, 95% CI: −25.25, −8.03, <em>p</em> &lt;0.001, <em>I</em><sup><em>2</em></sup> = 74%). Additionally, the impact of this vitamin on uric acid concentrations was robust in the leave-one-out sensitivity analysis.</p></div><div><h3>Discussion</h3><p>Given that few clinical trials were included, the number of subjects analyzed was limited. However, our results suggest that vitamin D administration is associated with a significant reduction in the levels of serum uric acid in randomized clinical trials.</p></div>","PeriodicalId":20049,"journal":{"name":"PharmaNutrition","volume":"28 ","pages":"Article 100391"},"PeriodicalIF":3.2,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141023292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Probiotics in plant-based food matrices: A review of their health benefits 植物性食品基质中的益生菌:健康益处综述
IF 3.2
PharmaNutrition Pub Date : 2024-05-09 DOI: 10.1016/j.phanu.2024.100390
Sara Sayonara da Cruz Nascimento , Thaís Souza Passos , Francisco Canindé de Sousa Júnior
{"title":"Probiotics in plant-based food matrices: A review of their health benefits","authors":"Sara Sayonara da Cruz Nascimento ,&nbsp;Thaís Souza Passos ,&nbsp;Francisco Canindé de Sousa Júnior","doi":"10.1016/j.phanu.2024.100390","DOIUrl":"10.1016/j.phanu.2024.100390","url":null,"abstract":"<div><h3>Background</h3><p>Plant-based food matrices have been increasingly used as vehicles for probiotics due to their high nutritional and bioactive value. Therefore, this review summarizes the health benefits of plant-based food matrices probiotics focusing on <em>in vitro</em> and <em>in vivo</em> studies.</p></div><div><h3>Methods</h3><p>A narrative literature review was performed to select articles published between 2015 and 2024. The Scopus, Science Direct, Web of Science, PubMed, and EMBASE scientific databases were used. Full articles that evaluated the health benefits of consuming plant-based food matrices probiotics performed <em>in vitro</em> and <em>in vivo</em> (animal models and clinical trials in humans) were selected.</p></div><div><h3>Results</h3><p>From the scientific evidence, it was possible to highlight the health benefits of probiotics in plant-based food matrices and their association with bioactive compounds treating various diseases, proving beneficial effects in treating cancer, liver diseases, obesity, and related chronic diseases and inflammatory diseases. However, it was noted that clinical trials are still needed to confirm these effects in humans.</p></div><div><h3>Conclusions</h3><p>Plant-based food matrices probiotics have proven beneficial effects in various diseases based on <em>in vitro</em> and animal model studies. However, clinical trials are needed to confirm these effects.</p></div>","PeriodicalId":20049,"journal":{"name":"PharmaNutrition","volume":"28 ","pages":"Article 100390"},"PeriodicalIF":3.2,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141025484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信